References
- Rai KR, Sawitsky A, Cronkite EP, et al Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
- Binet JL, Lepoprier M, Dighiero G, et al A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855–864.
- Hamblin TJ, Davis Z, Gardiner A, et al Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
- Wiestner A, Rosenwald A, Barry TS, et al ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944–4951.
- Hamblin TJ, Orchard JA, Ibbotson RE, et al CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002;99:1023–1029.
- Hamblin TJ. Predicting progression–ZAP-70 in CLL. N Engl J Med 2004;351:856–857.
- Crespo M, Bosch F, Villamor N, et al ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764–1775.
- Döhner H, Stilgenbauer S, Benner A, et al Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910–1916.
- Krober A, Seiler T, Benner A, et al V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410–1416.
- Nückel H, Frey UH, Bau M, et al Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 2007;109:290–297.
- Kaderi MA, Norberg M, Murray F, et al The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia. Leukemia 2008;22:339–343.
- Majid A, Tsoulakis O, Walewska R, et al BCL2 expression in chronic lymphocytic leukemia (CLL): lack of association with the BCL2-938A>C promoter single nucleotide polymorphism (SNP). Blood 2008;111:874–877.
- Rossi D, Rasi S, Capello D, et al Prognostic assessment of BCL2 C938A polymorphism in chronic lmphocytic leukemia. Blood 2008;111:466–468.
- Krober A, Bloehdorn J, Hafner S, et al Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 2006;24:969–975.
- van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16:219–242.
- Korn EL. Censoring distributions as a measure of follow-up in survival analysis. Stat Med 1986;5:255–260.